Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

498
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
498
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

25
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
25

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Directed Ablative Techniques for Autonomously Functioning Thyroid Nodules: A Statement from the North American Society for Interventional Thyroidology.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Approach to the Patient with Low-Risk Thyroid Cancer.

The Journal of clinical endocrinology and metabolism·2026
Same author

Advancements and Insights in Thyroid Health.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Barriers for Secondary Hypertension Screening in the United States: A National Physician Survey.

Journal of the American Heart Association·2026
Same author

Survival Outcomes Associated with Hypothyroidism Following Cancer Therapies.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Navigating Thyroid Hormone Deprescribing in Older Adults.

JAMA·2026

Related Experiment Video

Updated: Apr 26, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.2K

Tree-based model for thyroid cancer prognostication.

Mousumi Banerjee1, Daniel G Muenz, Joanne T Chang

  • 1Department of Biostatistics (M.B., D.G.M.); Department of Epidemiology (J.T.C.), School of Public Health; Division of Metabolism, Endocrinology, and Diabetes, Department of Medicine (M.P., M.R.H.), University of Michigan Health System, University of Michigan, Ann Arbor, Michigan 48109.

The Journal of Clinical Endocrinology and Metabolism
|July 18, 2014
PubMed
Summary
This summary is machine-generated.

This study identified four distinct prognostic groups for well-differentiated thyroid cancer, highlighting patient age and SEER stage as key survival predictors. These findings aid in patient education and treatment strategies for thyroid cancer.

More Related Videos

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K

Related Experiment Videos

Last Updated: Apr 26, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

1.2K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.1K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K

Area of Science:

  • Endocrinology
  • Oncology
  • Epidemiology

Background:

  • Thyroid cancer survival prediction factors are not well-understood.
  • Accurate prognostic models are needed for effective patient management.

Purpose of the Study:

  • To assess prognostic effects of patient, tumor, and treatment factors in thyroid cancer.
  • To define distinct prognostic groups for thyroid cancer survival.

Main Methods:

  • Analysis of 43,392 well-differentiated thyroid cancer cases (1998-2005) from the SEER database.
  • Multivariable analyses using Cox regression, survival trees, and random survival forest.
  • Validation using National Cancer Data Base data for overall survival.

Main Results:

  • Four distinct prognostic groups for disease-specific survival (DSS) were identified (P < .0001).
  • Five-year DSS rates were 100%, 98%, 91%, and 64%; 10-year rates were 100%, 96%, 85%, and 50%.
  • Age at diagnosis and SEER stage were the most significant predictors for DSS and overall survival (OS).

Conclusions:

  • Distinct prognostic groups for thyroid cancer have been identified.
  • Patient age is a critical factor for both disease-specific and overall survival.
  • Findings support improved patient education and tailored thyroid cancer treatment strategies.